Latham & Watkins Advises on US$5.4 Billion Acquisition of Wright Medical by Stryker

Wright Medical Group N.V. has announced that it has entered into a definitive agreement under which Stryker Corporation will acquire all of the issued and outstanding ordinary shares of Wright for total enterprise value of approximately US$5.4 billion. The acquisition is expected to close in the second half of 2020 subject to receipt of applicable regulatory approvals, the adoption of certain resolutions relating to the transaction at an extraordinary general meeting of Wright’s shareholders, completion of the tender offer and other customary closing conditions. 

Latham & Watkins LLP represents the financial advisors, Guggenheim Securities, LLC and J.P. Morgan Securities LLC, to Wright in the transaction with a corporate team led by Orange County partner Charles Ruck with associate Brian Umanoff. Advice was also provided on compliance matters by Orange County partner Michele Johnson and on competition matters by Washington, D.C. partner Mandy Reeves.